Jacorrian’s Story | See abbv.ie/RinvoqPI | RINVOQ UC Testimonial 2

Описание: See Prescribing Info, including BOXED WARNING & Medication Guide, at http://abbv.ie/RinvoqPI

Jacorrian is 25 years old and living with moderate to severe ulcerative colitis (UC). After being disappointed with multiple medications that didn’t work, he finally put his UC in check with RINVOQ. Now that he’s seen symptom improvement, he’s back in charge of his life—focused on his graphic design work instead of running to the bathroom. See why UC won’t stop Jacorrian.

About RINVOQ

RINVOQ is a prescription medicine used to treat adults with moderate to severe ulcerative colitis when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated. It is not known if RINVOQ is safe and effective in children with ulcerative colitis.

SAFETY CONSIDERATIONS

RINVOQ may cause serious side effects, including:

Serious infections. RINVOQ can lower ability to fight infections. Serious infections, some fatal, occurred, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses.

Increased risk of death in people age 50+ with at least 1 heart disease risk factor.

Cancer and immune system problems. Increased risk of some cancers, including lymphoma and skin. Current or past smokers have higher risk for lymphoma and lung cancer.

Increased risk of major cardiovascular events such as heart attack, stroke, or death in people 50+ with at least 1 heart disease risk factor, especially in current or past smokers.

Blood clots, some fatal, in veins of the legs or lungs and arteries. This occurred more often in people 50+ with at least 1 heart disease risk factor.

Serious allergic reactions. Do not take if allergic to RINVOQ or its ingredients.

Tears in the stomach or intestines; changes in certain laboratory test results.

For additional Important Safety Information, visit http://abbv.ie/RinvoqISI

Learn more about RINVOQ for UC at https://www.rinvoq.com/ulcerative- colitis